Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Avicanna Inc. Management Reports 2021

Nov 16, 2021

47531_rns_2021-11-16_bbe540fe-1a56-4c9e-8f0d-d68c08a83451.pdf

Management Reports

Open in viewer

Opens in your device viewer

==> picture [65 x 10] intentionally omitted <==

==> picture [65 x 19] intentionally omitted <==

==> picture [65 x 20] intentionally omitted <==

==> picture [65 x 10] intentionally omitted <==

==> picture [65 x 10] intentionally omitted <==

==> picture [365 x 79] intentionally omitted <==

Date: November 16, 2021

VIA SEDAR

Ontario Securities Commission British Columbia Securities Commission Alberta Securities Commission Manitoba Securities Commission Financial and Consumer Affairs Authority of Saskatchewan

Dear Sirs/Mesdames,

Re: Avicanna Inc. (the “Company” or “Avicanna”) – Amended Management’s Discussion and Analysis for the three and nine months ended September 30, 2021 SEDAR Project No. 03300712:

The Company is filing today its amended Management’s Discussion and Analysis for the three and nine months ended September 30, 2021 (the “MD&A”), which amend the Company’s Management’s Discussion and Analysis for the same period originally filed on SEDAR on November 12, 2021.

The MD&A has been updated to correct a number of typographical errors in tables disclosing details on Gross Margins, Selected Consolidated Financial Information, Other Income (Expenses) and adjusted EBITDA. The changes are for presentation purposes and no figures have been restated. These typographical errors included incorrect dates and positive numbers shown as negative numbers, causing inconsistency between the MD&A and the condensed consolidated interim financial statements for the same period.

Your Truly,

AVICANNA INC.

(Signed) Davender Sohi

Davender Sohi, CPA, CA, CBV Chief Financial officer